Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. (TCRT): 13 pipeline candidates · ~2 mo cash runway · 11 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
1.6 months
D/E 0.46 · 0% dilution
Lead: Phase 2
13 candidates
N/A
N/A
A transparent, data-derived signal for Alaunos Therapeutics, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$5.6M
Cash
$354K
Quarterly Burn
$1.0M
Runway
1.6 mo
Revenue
$0
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (13 candidates)
| Drug | Phase |
|---|---|
| ad-rts-hil-12 | Phase 2 |
| aldesleukin | Phase 1/Phase 2 |
| aln1001 | Preclinical |
| aln1003 | Preclinical |
| cemiplimab | Phase 2 |
| inxn-1001 | Phase 1/Phase 2 |
| inxn-2001 | Phase 1/Phase 2 |
| neoantigen specific tcr-t cell drug product | Phase 1/Phase 2 |
| oral veledimex - arm 1 | Phase 2 |
| oral veledimex - arm 2 | Phase 2 |
Showing 10 of 13 candidates. Sign up for full pipeline.
Frequently asked questions
How many drug candidates are in Alaunos Therapeutics, Inc.'s pipeline?
Alaunos Therapeutics, Inc. (TCRT) has 13 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Alaunos Therapeutics, Inc.'s lead drug candidate?
Alaunos Therapeutics, Inc.'s most advanced tracked candidate is ad-rts-hil-12 (Phase 2) for Glioblastoma; Metastatic Breast Cancer; Pediatric Brain Tumor.
What is Alaunos Therapeutics, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Alaunos Therapeutics, Inc. has approximately 1.6 months of cash runway.
What is Alaunos Therapeutics, Inc.'s market capitalization?
Alaunos Therapeutics, Inc.'s market capitalization is approximately $5.6M.
Who is the CEO of Alaunos Therapeutics, Inc.?
Mr. Holger Weis CPA is the chief executive officer of Alaunos Therapeutics, Inc. (TCRT).
Get the full picture on Alaunos Therapeutics, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.